## Management of Giant Cell Tumor: Adjuvant Techniques ### Recurrence Problem in GCT **Key Point:** GCT has a high recurrence rate (10–65%) when treated with curettage alone, primarily due to incomplete removal of tumor cells from the cavity walls and the locally aggressive nature of the lesion. ### Adjuvant Techniques to Reduce Recurrence | Adjuvant | Mechanism | Recurrence Rate | Advantages | Disadvantages | |----------|-----------|-----------------|------------|----------------| | **Phenol** | Chemical cauterization of residual tumor cells | 10–20% | Inexpensive, effective, preserves function | Requires careful hemostasis; risk of systemic toxicity if absorbed | | **Cryotherapy** (liquid nitrogen) | Thermal destruction of tumor cells | 10–15% | Effective, no systemic toxicity | Equipment dependent, risk of articular damage if applied near joint | | **Cement (PMMA)** | Mechanical fill + thermal effect | 15–25% | Fills cavity, prevents collapse | Difficult removal if revision needed | | **Curettage alone** | No adjuvant | 50–65% | Simple, quick | Highest recurrence | | **Wide excision** | En bloc removal with margin | <5% | Lowest recurrence | Functional loss, not first-line for benign tumor | **High-Yield:** **Phenol and cryotherapy are the two most commonly used adjuvants in NEET PG exams.** Phenol is preferred in resource-limited settings and is the gold standard in many Indian centers. ### Phenol Application Protocol 1. **Thorough curettage** of the lesion cavity 2. **Hemostasis** — essential to prevent systemic absorption 3. **Phenol application** — 90% solution, 3–5 minutes contact time 4. **Copious saline irrigation** — to remove residual phenol 5. **Filling** — with bone graft or cement **Clinical Pearl:** Phenol is neurotoxic and cardiotoxic if absorbed systemically; careful hemostasis and irrigation are non-negotiable to prevent complications. ### Why This Patient Had Recurrence The patient likely underwent **simple curettage without adjuvant** at the initial surgery, which explains the high recurrence rate (50–65% expected). Adding phenol or cryotherapy would have reduced this to 10–20%. **Warning:** ~~Wide excision (rotationplasty)~~ is reserved for malignant tumors or recurrent GCT with extensive bone loss—not first-line for initial benign GCT, as it causes significant functional morbidity. ### Mnemonic: **ADJUVANT** for GCT - **A**pply phenol or cryo - **D**estroy residual cells - **J**ust after curettage - **U**se hemostasis first - **V**oid recurrence (reduce from 50% to 10–20%) - **A**void wide excision (first-line) - **N**eed careful irrigation - **T**hermal or chemical technique [cite:Robbins 10e Ch 28; Canale & Beaty Orthopaedic Surgery Ch 28] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.